Literature DB >> 19523185

Editorial: Pursuing efficiency: a dead end for HTA?

J Jaime Caro.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19523185     DOI： 10.1111/j.1524-4733.2009.00559.x

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Does it Matter Whether Canada's Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Authors:  Jeffrey S Hoch; Jaclyn Beca; Mona Sabharwal; Scott W Livingstone; Anthony L A Fields
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.